Skip Navigation

Archive-It

Facebook iconTwitter iconWordpress icon

FDA.gov

Collected by: U.S Food and Drug Administration

Archived since: Oct, 2016

Description:

Snapshot of the www.FDA.gov website

Subject:   Science & Health Government - US Federal

Enter a search term on the right to search the text within the archived pages. Or for more search options, use the Advanced Search options below.

Advanced Search

Capture date range:

From:
To:

? Help with Search

Page 1 of 156 (3,111 Total Results)Next Page ►

Sort By:

FDA Announces Withdrawal of Draft Guidance for Industry #230 Regarding Animal Drug Compounding

URL: https://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm580525.htm

This text was captured  on Jul 26, 2018   Show All Captures

FDA Announces Withdrawal of Draft Guidance for Industry #230 Regarding Animal Drug Compounding Skip to main page content Skip to search Skip to topics menu Skip to common links HHS U.S.

Content: application/xhtml+xml Size: 37 KB

FDA Announces Withdrawal of Draft Guidance for Industry #230 Regarding Animal Drug Compounding | FDA

URL: https://www.fda.gov/node/375075

This text was captured  on Dec 17, 2019   Show All Captures

of Draft Guidance for Industry #230 Regarding Animal Drug Compounding CVM Updates FDA Announces Withdrawal of Draft Guidance for Industry #230 Regarding Animal Drug Compounding Share Tweet Linkedin Email

Content: text/html Size: 32 KB

FDA Announces Withdrawal of Draft Guidance for Industry #230 Regarding Animal Drug Compounding | FDA

URL: https://www.fda.gov/animal-veterinary/cvm-updates/fda-announces-withdrawal-draft-guidance-industry-230-regarding-animal-drug-compounding

This text was captured  on Oct 01, 2019   Show All Captures

of Draft Guidance for Industry #230 Regarding Animal Drug Compounding CVM Updates FDA Announces Withdrawal of Draft Guidance for Industry #230 Regarding Animal Drug Compounding Share Tweet Linkedin Email

Content: text/html Size: 35 KB

Withdrawn /Replaced Guidances

URL: https://www.fda.gov/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm055752.htm

This text was captured  on Nov 14, 2017   Show All Captures

04/13/2011 182 VICH GL42 - Pharmacovigilance of Veterinary Medicinal Products: Data Elements for Submission of Adverse Event Reports Withdrawn 01/17/2014; harmonized under Guidance 188 230 Draft GFI #230

Content: application/xhtml+xml Size: 41 KB

Withdrawn/Replaced Guidances | FDA

URL: https://www.fda.gov/node/354400

This text was captured  on Oct 18, 2019   Show All Captures

harmonized under Guidance 188 230 Draft GFI #230 – Compounding Animal Drugs from Bulk Drug Substances Withdrawn 11/7/2017 Content current as of: 09/27/2019 Guidance for Industry Guidance by Number Guidances

Content: text/html Size: 42 KB

Withdrawn/Replaced Guidances | FDA

URL: https://www.fda.gov/animal-veterinary/guidance-industry/withdrawnreplaced-guidances

This text was captured  on Dec 11, 2019   Show All Captures

Consumers Patients Industry Health Professionals Federal, State and Local Officials In this section : Guidance for Industry Guidance for Industry Guidance by Number Guidances Under Development for 2019

Content: text/html Size: 40 KB

FDA/CVM Releases Draft Guidance on Animal Drug Compounding from Bulk Drug Substances

URL: http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm446846.htm

This text was captured  on Jan 12, 2017   Show All Captures

Food and Drug Administration today released a draft “Guidance for Industry (GFI) #230 , Compounding Animal Drugs from Bulk Drug Substances .”

Content: application/xhtml+xml Size: 41 KB

FDA/CVM Releases Draft Guidance on Animal Drug Compounding from Bulk Drug Substances

URL: https://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm446846.htm

This text was captured  on Apr 06, 2017   Show All Captures

Food and Drug Administration today released a draft “Guidance for Industry (GFI) #230 , Compounding Animal Drugs from Bulk Drug Substances .”

Content: application/xhtml+xml Size: 41 KB

FDA releases draft guidance on animal drug compounding from bulk drug substances

URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm447159.htm

This text was captured  on Apr 06, 2017   Show All Captures

For more information: Draft Guidance for Industry #230 : Compounding Animal Drugs from Bulk Drug Substances Federal Register Notice of Availability; Draft Guidance for Industry : Compounding Animal Drugs

Content: application/xhtml+xml Size: 41 KB

FDA releases draft guidance on animal drug compounding from bulk drug substances

URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm447159.htm

This text was captured  on Jan 11, 2017   Show All Captures

For more information: Draft Guidance for Industry #230 : Compounding Animal Drugs from Bulk Drug Substances Federal Register Notice of Availability; Draft Guidance for Industry : Compounding Animal Drugs

Content: application/xhtml+xml Size: 42 KB

FDA In Brief: FDA issues draft guidance on compounding certain animal drugs from bulk drug substances | FDA

URL: https://www.fda.gov/news-events/fda-brief/fda-brief-fda-issues-draft-guidance-compounding-certain-animal-drugs-bulk-drug-substances

This text was captured  on Dec 13, 2019   Show All Captures

The FDA previously published draft guidance GFI #230 , “Compounding Animal Drugs from Bulk Drug Substances” for public comment in May 2015.

Content: text/html Size: 37 KB

FDA Releases Revised Draft Guidance on Compounding Animal Drugs from Bulk Drug Substances | FDA

URL: https://www.fda.gov/animal-veterinary/cvm-updates/fda-releases-revised-draft-guidance-compounding-animal-drugs-bulk-drug-substances

This text was captured  on Dec 12, 2019   Show All Captures

The FDA previously published draft guidance on this issue for public comment in May 2015 (Draft GFI #230 , “Compounding Animal Drugs from Bulk Drug Substances”).

Content: text/html Size: 40 KB

Introduction - Enforcement Story

URL: https://www.fda.gov/ICECI/EnforcementActions/EnforcementStory/EnforcementStoryArchive/ucm091132.htm

This text was captured  on Feb 13, 2019   Show All Captures

The statements made herein are not intended to create or confer any rights, privileges, or benefits on or for any private person, but are intended merely for internal guidance .

Content: application/xhtml+xml Size: 35 KB

Draft Guidance for Industry: Regulatory Procedures Manual Chapter 9 Subchapter on Recommending Customs' Seizure and Destruction of Imported Human and Animal Food That Has Not Been Reconditioned | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/draft-guidance-industry-regulatory-procedures-manual-chapter-9-subchapter-recommending-customs

This text was captured  on Sep 06, 2019   Show All Captures

Consumers Patients Industry Health Professionals Federal, State and Local Officials In this section : Search for FDA Guidance Documents Search for FDA Guidance Documents Search General and Cross-Cutting

Content: text/html Size: 51 KB

Draft Guidance for Industry: Regulatory Procedures Manual Chapter 9 Subchapter on Recommending Customs' Seizure and Destruction of Imported Human and Animal Food That Has Not Been Reconditioned | FDA

URL: https://www.fda.gov/node/356080

This text was captured  on Dec 13, 2019   Show All Captures

Human and Animal Food That Has Not Been Reconditioned Search for FDA Guidance Documents GUIDANCE DOCUMENT Draft Guidance for Industry : Regulatory Procedures Manual Chapter 9 Subchapter on Recommending

Content: text/html Size: 48 KB

Fast Track Designation Request Performance

URL: https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CBER/ucm122932.htm

This text was captured  on Apr 03, 2017   Show All Captures

Details on the FDA fast track program, including Section 112 of FDAMA and the proposed and final rules in the Federal Register can be found in the Guidance for Industry : Expedited Programs for Serious

Content: application/xhtml+xml Size: 37 KB

FDA approves nilotinib for pediatric patients with newly diagnosed or resistant/intolerant Ph+ CML in chronic phase | FDA

URL: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-nilotinib-pediatric-patients-newly-diagnosed-or-resistantintolerant-ph-cml-chronic

This text was captured  on Dec 22, 2020   Show All Captures

A description of FDA expedited programs is in the Guidance for Industry : Expedited Programs for Serious Conditions-Drugs and Biologics, available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation

Content: text/html Size: 36 KB

FDAAA Implementation Chart

URL: https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FoodandDrugAdministrationAmendmentsActof2007/FDAAAImplementationChart/index.htm

This text was captured  on Nov 04, 2017   Show All Captures

for Stay of Action 4/2/09 HTML or PDF Final Guidance for Industry : Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act published 6/

Content: application/xhtml+xml Size: 91 KB

FDAAA Implementation Chart

URL: https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FoodandDrugAdministrationAmendmentsActof2007/FDAAAImplementationChart/default.htm

This text was captured  on Nov 14, 2017   Show All Captures

for Stay of Action 4/2/09 HTML or PDF Final Guidance for Industry : Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act published 6/

Content: application/xhtml+xml Size: 91 KB

Page 1 of 156 (3,111 Total Results)Next Page ►